25 November, 2024
29th Annual Meeting of the Society for Neuro-Oncology
Publications & Presentations
Publications and Presentations
-
(0)
-
(6)
-
(1)
-
(2)
-
(1)
-
(4)
26 July, 2024
Pediatric Blood Cancer
A Phase 1 Trial of TPI 287 as a Single Agent and in Combination with Temozolomide in Patients with Refractory or Recurrent Neuroblastoma or Medulloblastoma
By: Deanna Mitchell, Genevieve Bergendahl, William Ferguson, William Roberts, et. al.
TPI 287
26 July, 2024
Final Results from the Dose-Escalation Stage of a Phase 1/2 Trial of TPI 287, a Brain Penetrable Microtubule Inhibitor, Plus Bevacizumab in Patients with Recurrent Glioblastoma
By: S. Goldlust, L. Nabors, III, P. Duin, N. Mobile, T. Benkers, et. al.
TPI 287
26 July, 2024
JAMANeurology
Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients with Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome
TPI 287
26 July, 2024
TPI-287, a New Taxane Family Member, Reduces the Brain Metastatic Colonization of Breast Cancer Cells
By: Daniel P. Fitzgerald, David L. Emerson, Yongzhen Qian, et. al.
TPI 287
18 July, 2024
Investor Presentation July 2024
There are no publications that match the selected filters.
By: